Clinical Trials Browser

OTHER_GOV × Bevacizumab × 30 days × Clear all

NCT05398861 2026-04-16

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Phase 2 Recruiting

HER-2 Negative Breast Cancer

NCT07293468 2026-04-09

BIIRTH

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05769010 2026-04-01

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

Phase 2 Recruiting

Breast Neoplasms